Here's the first part of an article about grants that are going to St. Louis' Washington University for breast cancer research:
Komen gives $5.4 million to Siteman for breast cancer research
St. Louis Business Journal by Greta Weiderman -Monday, June 4, 2012
Susan G. Komen for the Cure has awarded more than $5 million in new grants to Washington University scientists at the Alvin J. Siteman Cancer Center to develop new breast cancer treatments, university officials said.
The largest portion – $4 million – will be used to better identify which women with estrogen receptor-positive breast cancer, the most common form of the disease, are at the greatest risk for recurrence, and to determine better treatments for them.
“There are so many new drugs out there for breast cancer patients that we need a way to establish which ones are most likely to be the home run,” said Matthew Ellis, professor of medicine and chief of the breast oncology section at Washington University School of Medicine. “Our goal is to screen drugs to find the one that will produce the best outcome for the patient with the least toxicity.”